{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:26:07Z","timestamp":1780478767684,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00774-023-01411-4","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T11:33:22Z","timestamp":1677756802000},"page":"248-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between pharmacotherapy and secondary hip fracture in a real-world setting: a nationwide database study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7928-0014","authenticated-orcid":false,"given":"Shinichi","family":"Nakatoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukazu","family":"Okimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumito","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Iki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"1411_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","volume":"15","author":"CM Klotzbuecher","year":"2000","unstructured":"Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721\u2013739","journal-title":"J Bone Miner Res"},{"key":"1411_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00198-017-4247-1","volume":"29","author":"A Frederiksen","year":"2018","unstructured":"Frederiksen A, Abrahamsen B, Johansen PB, S\u00f8rensen HA (2018) Danish, national cross-sectional observational study on the prevalence of prior major osteoporotic fractures in adults presenting with hip fracture-limitations and scope for fracture liaison services in prevention of hip fracture. Osteoporos Int 29:109\u2013114","journal-title":"Osteoporos Int"},{"key":"1411_CR3","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s00198-016-3542-6","volume":"27","author":"JPW Bynum","year":"2016","unstructured":"Bynum JPW, Bell JE, Cantu RV, Wang Q, McDonough CM, Carmichael D, Tosteson TD, Tosteson ANA (2016) Second fractures among older adults in the year following hip, shoulder, or wrist fracture. Osteoporos Int 27:2207\u20132215","journal-title":"Osteoporos Int"},{"key":"1411_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12877-016-0332-0","volume":"16","author":"Dyer SM, Crotty M, Fairhall N, Magaziner J, Beaupre LA, Cameron ID, Sherrington C; Fragility Fracture Network (FFN) Rehabilitation Research Special Interest Group","year":"2016","unstructured":"Dyer SM, Crotty M, Fairhall N, Magaziner J, Beaupre LA, Cameron ID, Sherrington C; Fragility Fracture Network (FFN) Rehabilitation Research Special Interest Group (2016) A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr 16:158","journal-title":"BMC Geriatr"},{"key":"1411_CR5","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/S2468-2667(17)30046-4","volume":"2","author":"N Papadimitriou","year":"2017","unstructured":"Papadimitriou N, Tsilidis KK, Orfanos P, Benetou V, Ntzani EE et al (2017) Burden of hip fracture using disability-adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium. Lancet Public Health 2:e239\u2013e246","journal-title":"Lancet Public Health"},{"key":"1411_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","volume":"15","author":"Borgstr\u00f6m F, Karlsson L, Orts\u00e4ter G, Norton N, Halbout P, Cooper C, Lorentzon M, McCloskey EV, Harvey NC, Javaid MK, Kanis JA; International Osteoporosis Foundation","year":"2020","unstructured":"Borgstr\u00f6m F, Karlsson L, Orts\u00e4ter G, Norton N, Halbout P, Cooper C, Lorentzon M, McCloskey EV, Harvey NC, Javaid MK, Kanis JA; International Osteoporosis Foundation (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15:59","journal-title":"Arch Osteoporos"},{"key":"1411_CR7","first-page":"1","volume":"11","author":"E Schemitsch","year":"2021","unstructured":"Schemitsch E, Adachi JD, Brown JP, Tarride JE, Burke N, Oliveira T, Slatkovska L (2021) Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients. Osteoporos Int 11:1\u201310","journal-title":"Osteoporos Int"},{"key":"1411_CR8","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s00198-017-4175-0","volume":"28","author":"T Saito","year":"2017","unstructured":"Saito T, Sterbenz JM, Malay S, Zhong L, MacEachern MP, Chung KC (2017) Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis. Osteoporos Int 28:3289\u20133300","journal-title":"Osteoporos Int"},{"key":"1411_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/os.12517","volume":"11","author":"PW Wang","year":"2019","unstructured":"Wang PW, Li YZ, Zhuang HF, Yu HM, Cai SQ, Xu H, Chen ZH, Lin JK, Yao XD (2019) Anti-osteoporosis medications associated with decreased mortality after hip fracture. Orthop Surg 11:777\u2013783","journal-title":"Orthop Surg"},{"key":"1411_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/jpm11050341","volume":"11","author":"R Dobre","year":"2021","unstructured":"Dobre R, Niculescu DA, Petca RC, Popescu RI, Petca A, Poian\u0103 C (2021) Adherence to anti-osteoporotic treatment and clinical implications after hip fracture: a systematic review. J Pers Med 11:341","journal-title":"J Pers Med"},{"key":"1411_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00774-013-0447-8","volume":"31","author":"Soen S, Fukunaga M, Sugimoto T, Sone T, Fujiwara S, Endo N, Gorai I, Shiraki M, Hagino H, Hosoi T, Ohta H, Yoneda T, Tomomitsu T, Japanese Society for Bone and Mineral Research and Japan Osteoporosis Society Joint Review Committee for the Revision of the Diagnostic Criteria for Primary Osteoporosis","year":"2013","unstructured":"Soen S, Fukunaga M, Sugimoto T, Sone T, Fujiwara S, Endo N, Gorai I, Shiraki M, Hagino H, Hosoi T, Ohta H, Yoneda T, Tomomitsu T, Japanese Society for Bone and Mineral Research and Japan Osteoporosis Society Joint Review Committee for the Revision of the Diagnostic Criteria for Primary Osteoporosis (2013) Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab 31:247\u2013257","journal-title":"J Bone Miner Metab"},{"key":"1411_CR12","unstructured":"Japan Osteoporosis Society (2015) Guidelines on the prevention and treatment of osteoporosis 2015. The committee for development of the guidelines on the prevention and treatment of osteoporosis. (in Japanese). http:\/\/www.josteo.com\/ja\/guideline\/doc\/15_1.pdf. Accessed 22 Sep 2022"},{"key":"1411_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11657-021-00992-9","volume":"16","author":"S Nakatoh","year":"2021","unstructured":"Nakatoh S, Fujimori K, Ishii S, Tamaki J, Okimoto N, Ogawa S, Iki M (2021) Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip and vertebral fracture: analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Arch Osteoporos 16:130","journal-title":"Arch Osteoporos"},{"key":"1411_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2147\/PPA.S131564","volume":"11","author":"YC Chen","year":"2017","unstructured":"Chen YC, Lin WC (2017) Poor 1st-year adherence to anti-osteoporotic therapy increases the risk of mortality in patients with magnetic resonance imaging-proven acute osteoporotic vertebral fractures. Patient Prefer Adherence 11:839\u2013843","journal-title":"Patient Prefer Adherence"},{"key":"1411_CR15","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00198-011-1668-0","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Cooper C, Hiligsmann M, Rabenda V, Reginster JY, Rizzoli R (2011) Partial adherence: a new perspective on health economic assessment in osteoporosis. Osteoporos Int 22:2565\u20132573","journal-title":"Osteoporos Int"},{"key":"1411_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11657-021-00993-8","volume":"16","author":"S Nakatoh","year":"2021","unstructured":"Nakatoh S, Fujimori K, Ishii S, Tamaki J, Okimoto N, Ogawa S, Iki M (2021) Insufficient persistence to pharmacotherapy in Japanese patients with osteoporosis: an analysis of the National Database of Health Insurance Claims and Specific Health Checkups in Japan. Arch Osteoporos 16:131","journal-title":"Arch Osteoporos"},{"key":"1411_CR17","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2019-00192","volume":"104","author":"P Barrionuevo","year":"2019","unstructured":"Barrionuevo P, Kapoor E, Asi N, Alahdab F, Mohammed K, Benkhadra K, Almasri J, Farah W, Sarigianni M, Muthusamy K, Al Nofal A, Haydour Q, Wang Z, Murad MH (2019) Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis. J Clin Endocrinol Metab 104:1623\u20131630","journal-title":"J Clin Endocrinol Metab"},{"key":"1411_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115081","volume":"130","author":"EL Simpson","year":"2020","unstructured":"Simpson EL, Martyn-St James M, Hamilton J, Wong R, Gittoes N, Selby P, Davis S (2020) Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: a systematic review and network meta-analysis. Bone 130:115081","journal-title":"Bone"},{"key":"1411_CR19","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/ggi.14485","volume":"22","author":"S Nakatoh","year":"2022","unstructured":"Nakatoh S, Fujimori K, Ishii S, Tamaki J, Okimoto N, Ogawa S, Iki M (2022) Association of pharmacotherapy with the second hip fracture incidence in women: a retrospective analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Geriatr Gerontol Int 22:930\u2013937","journal-title":"Geriatr Gerontol Int"},{"key":"1411_CR20","unstructured":"Ministry of Health, Labour, and Welfare (2020) The popularization and state of electronic receipt claims. https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-12400000-Hokenkyoku\/0000099002.pdf. (in Japanese) Accessed 22 Sep 2022"},{"key":"1411_CR21","unstructured":"The Japanese Orthopaedic Association (2020) Results of National Survey of hip fracture in 2020. (in Japanese). https:\/\/www.joa.or.jp\/member\/committee\/osteoporosis\/pdf\/femur20.pdf. Accessed 22 Sep 2022"},{"key":"1411_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/0269215514542358","volume":"29","author":"S Liu","year":"2015","unstructured":"Liu S, Zhu Y, Chen W, Sun T, Cheng J, Zhang Y (2015) Risk factors for the second contralateral hip fracture in elderly patients: a systematic review and meta-analysis. Clin Rehabil 29:285\u2013294","journal-title":"Clin Rehabil"},{"key":"1411_CR23","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00590-019-02412-8","volume":"29","author":"HQ Sheikh","year":"2019","unstructured":"Sheikh HQ, Hossain FS, Khan S, Usman M, Kapoor H, Aqil A (2019) Short-term risk factors for a second hip fracture in a UK population. Eur J Orthop Surg Traumatol 29:1055\u20131060","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"1411_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/jbmr.3877","volume":"35","author":"RB Conley","year":"2020","unstructured":"Conley RB, Adib G, Adler RA, \u00c5kesson KE, Alexander IM et al (2020) Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition. J Bone Miner Res 35:36\u201352","journal-title":"J Bone Miner Res"},{"key":"1411_CR25","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00198-020-05294-3","volume":"31","author":"RL Barron","year":"2020","unstructured":"Barron RL, Oster G, Grauer A, Crittenden DB, Weycker D (2020) Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 31:2103\u20132111","journal-title":"Osteoporos Int"},{"key":"1411_CR26","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1007\/s00198-018-4759-3","volume":"29","author":"CT Yeam","year":"2018","unstructured":"Yeam CT, Chia S, Tan HCC, Kwan YH, Fong W, Seng JJB (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int 29:2623\u20132637","journal-title":"Osteoporos Int"},{"key":"1411_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/ard.2008.092775","volume":"68","author":"TA van Geel","year":"2009","unstructured":"van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ (2009) Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 68:99\u2013102","journal-title":"Ann Rheum Dis"},{"key":"1411_CR28","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00198-016-3868-0","volume":"28","author":"H Johansson","year":"2017","unstructured":"Johansson H, Siggeirsd\u00f3ttir K, Harvey NC, Od\u00e9n A, Gudnason V, McCloskey E, Sigurdsson G, Kanis JA (2017) Imminent risk of fracture after fracture. Osteoporos Int 28:775\u2013780","journal-title":"Osteoporos Int"},{"key":"1411_CR29","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00198-018-4502-0","volume":"29","author":"JA Kanis","year":"2018","unstructured":"Kanis JA, Johansson H, Od\u00e9n A, Harvey NC, Gudnason V, Sanders KM, Sigurdsson G, Siggeirsdottir K, Fitzpatrick LA, Borgstr\u00f6m F, McCloskey EV (2018) Characteristics of recurrent fractures. Osteoporos Int 29:1747\u20131757","journal-title":"Osteoporos Int"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-023-01411-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-023-01411-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-023-01411-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T02:16:11Z","timestamp":1679883371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-023-01411-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1411"],"URL":"https:\/\/doi.org\/10.1007\/s00774-023-01411-4","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"29 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S. Nakatoh has received payments for lectures, including speakers' bureau fees, from Asahi-Kasei Pharmaceutical Co., Ltd.; Amgen K.K.; and Astellas Pharma Inc. N. Okimoto has received consulting fees from Asahi-Kasei Pharmaceutical Co., Ltd. and Teijin Pharma Ltd. N. Okimoto has received payments for lectures, including speakers' bureau fees from Asahi-Kasei Pharmaceutical Co., Ltd.; Amgen Astellas Bio Pharma K.K.; Astellas Pharma Inc.; Chugai Pharmaceutical Co.; Daiichi-Sankyo Co., Ltd.; Eisai Co., Ltd.; Eli Lilly Japan; and Teijin Pharma Ltd. The other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the principles of the Declaration of Helsinki and was approved by the Ethics Committee of Kindai University Faculty of Medicine (approval number: 31\u2013065).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study data were completely anonymized. All data used in our analysis were deidentified by the Ministry of Health, Labour and Welfare. This study was performed in accordance with the guidelines of the Ministry of Information Security. Thus, informed consent was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and consent for publication"}},{"value":"The data in this study were completely anonymous. All data used in our analysis were deidentified by the Ministry of Health, Labour and Welfare, and this study followed the guidelines of the Ministry of Information Security. Thus, informed consent was not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}